Gallstone disease other imaging findings: Difference between revisions

Jump to navigation Jump to search
Line 22: Line 22:
===Oral cholecystography===
===Oral cholecystography===


Tests that are rarely done
Oral cholecystography is rarely done since being replaced by the transabdominal ultrasound. It is still occasionally use prognostically to evaluate gall bladder function in obese patients on medical dissolution therapy such as ursodeoxycholic acid where a high quality ultrasound cannot be obtained.<ref name="pmid7979854">{{cite journal |vauthors=Shea JA, Berlin JA, Escarce JJ, Clarke JR, Kinosian BP, Cabana MD, Tsai WW, Horangic N, Malet PF, Schwartz JS |title=Revised estimates of diagnostic test sensitivity and specificity in suspected biliary tract disease |journal=Arch. Intern. Med. |volume=154 |issue=22 |pages=2573–81 |year=1994 |pmid=7979854 |doi= |url=}}</ref>
Oral cholecystography can diagnose gallstones and assess gallbladder function, but it has largely been replaced by more sensitive and specific tests, such as transabdominal ultrasound [33,55]. It is still occasionally used in patients in whom a high-quality ultrasound examination cannot be obtained (such as in obese patients), to confirm the presence of adenomyomatosis of the gallbladder, and to evaluate patients who are being considered for medical dissolution therapy with ursodeoxycholic acid, in whom it is important to demonstrate stone number and size, relative density of the stones to bile, cystic duct patency, and the gallbladder's concentrating ability. (See "Patient selection for the nonsurgical treatment of gallstone disease".)
 
An orally administered contrast agent (eg, iopanoic acid, sodium tyropanoate, or calcium ipodate) is given and is absorbed through the intestine, taken up by the liver, and secreted into bile. Gallstones appear as filling defects within the contrast on plain radiographs (image 5). Non-opacification of the gallbladder can occur due to poor absorption from the intestine, impaired liver function, or extrahepatic biliary obstruction. With the currently available oral contrast agents, it is unlikely that the gallbladder will be visualized if the serum bilirubin is greater than 2 to 3 mg/dL.
 
An approximation of gallbladder motor function can also be obtained using oral cholecystography. The patient is given a fatty meal and serial radiographs are obtained. If the gallbladder is functioning normally, there will be a decrease in gallbladder size over time. Evaluation of the gallbladder motor function is not recommended in patients who have known gallbladder stones since it may induce biliary colic or complications of gallstone disease.


==References==
==References==

Revision as of 18:02, 1 December 2017

Gallstone disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Gallstone disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Lithotripsy
Surgical management

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Gallstone disease other imaging findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Gallstone disease other imaging findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Gallstone disease other imaging findings

CDC on Gallstone disease other imaging findings

Gallstone disease other imaging findings in the news

Blogs on Gallstone disease other imaging findings

Directions to Hospitals Treating Gallstone disease

Risk calculators and risk factors for Gallstone disease other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]

Overview

There are other imaging modalities that can be useful in diagnosing gallstone disease, these include; endoscopic retrograde cholangiopancreatography (ERCP), bile microscopy and oral cholecystography. It should be noted however, that some of these have been replaced by non-invasive, more advanced and less expensive imaging techniques.

Endoscopic retrograde cholangiopancreatography

Endoscopic retrograde cholangiopancreaticogram (ERCP) is an invasive procedure that requires technical expertise and often performed by inserting a tube into the common bile duct while the patient is sedated. Contrast material is then injected to allow visualization of the biliary tree. Traditionally, ERCP was not only diagnostic but is also therapeutic, so that if a stone was detected, it could be removed in the same sitting. The sensitivity of ERCP for choledocholithiasis is estimated to be 80 - 93%. ERCP has largely been replaced by MRCP and is now reserved for patients at a high risk of having a common bile duct stone, particularly with cholangitis.[1][2][3]


Source:wikiwand[4]

Bile microscopy

Patients whom exhibit symptoms of biliary colic where ultrasound fails to detect stones often turn to microscopic analysis of their bile as proof of microlithiasis. It has an overall sensitivity of 65 to 90 percent for identifying patients with gallstones.[5][6] The test detects traces of cholesterol crystals or bilirubinate granules. A high number of patients whom had clear ultrasounds had positive results on microscopy, however, the high sensitivity of tranabdominal ultrasonography has made the need for microscopy rare. [7][8]


Oral cholecystography

Oral cholecystography is rarely done since being replaced by the transabdominal ultrasound. It is still occasionally use prognostically to evaluate gall bladder function in obese patients on medical dissolution therapy such as ursodeoxycholic acid where a high quality ultrasound cannot be obtained.[9]

References

  1. Prat F, Amouyal G, Amouyal P, Pelletier G, Fritsch J, Choury AD, Buffet C, Etienne JP (1996). "Prospective controlled study of endoscopic ultrasonography and endoscopic retrograde cholangiography in patients with suspected common-bileduct lithiasis". Lancet. 347 (8994): 75–9. PMID 8538344.
  2. Gurusamy KS, Giljaca V, Takwoingi Y, Higgie D, Poropat G, Štimac D, Davidson BR (2015). "Endoscopic retrograde cholangiopancreatography versus intraoperative cholangiography for diagnosis of common bile duct stones". Cochrane Database Syst Rev (2): CD010339. doi:10.1002/14651858.CD010339.pub2. PMID 25719222.
  3. Tse F, Liu L, Barkun AN, Armstrong D, Moayyedi P (2008). "EUS: a meta-analysis of test performance in suspected choledocholithiasis". Gastrointest. Endosc. 67 (2): 235–44. doi:10.1016/j.gie.2007.09.047. PMID 18226685.
  4. "www.wikiwand.com".
  5. Delchier JC, Benfredj P, Preaux AM, Metreau JM, Dhumeaux D (1986). "The usefulness of microscopic bile examination in patients with suspected microlithiasis: a prospective evaluation". Hepatology. 6 (1): 118–22. PMID 3943777.
  6. Moskovitz M, Min TC, Gavaler JS (1986). "The microscopic examination of bile in patients with biliary pain and negative imaging tests". Am. J. Gastroenterol. 81 (5): 329–33. PMID 3706246.
  7. Sedaghat A, Grundy SM (1980). "Cholesterol crystals and the formation of cholesterol gallstones". N. Engl. J. Med. 302 (23): 1274–7. doi:10.1056/NEJM198006053022302. PMID 7366692.
  8. Gollish SH, Burnstein MJ, Ilson RG, Petrunka CN, Strasberg SM (1983). "Nucleation of cholesterol monohydrate crystals from hepatic and gall-bladder bile of patients with cholesterol gall stones". Gut. 24 (9): 836–44. PMC 1420078. PMID 6884818.
  9. Shea JA, Berlin JA, Escarce JJ, Clarke JR, Kinosian BP, Cabana MD, Tsai WW, Horangic N, Malet PF, Schwartz JS (1994). "Revised estimates of diagnostic test sensitivity and specificity in suspected biliary tract disease". Arch. Intern. Med. 154 (22): 2573–81. PMID 7979854.

Template:WH Template:WS